Improved
6112 HealthChanged
3786 LivesSaved
3568 Lives0 lives impacted in the last 24 hrs Learn More
Dr. Chap recalls her favorite experience with a cancer patient.
Dr. Chap:
Oh boy, there are so many, and the patients in themselves are an inspiration. It’s amazing that the strength the patients can actually bring with the diagnosis of cancer; it amazes me every day. I have so many stories; it’s really hard to hone in on to what’s a favorite one or what’s the most uplifting one, and so many of my patients I actually become friends with in the course of their treatment.
But one patient in particular that I like to talk about is a woman who was diagnosed with advanced breast cancer, meaning that it had spread to other areas in her body, including the liver, just about 14 years ago, and I can always remember distinctly because I had to give her that news just as I was going off on maternity leave.
Well, she was a patient who was put on a clinical trial at that time, got the drug, and here she is, 14 years later, and she is doing absolutely fine. So, I mean really, this was a patient who the books would have said six months, and by virtue of participating in a clinical trial where really we didn’t know what to expect, but we were hoping it was better than standard therapy, she has beaten all the odds.
About Dr. Linnea Chap, M.D.:
Linnea Chap, M.D., is a medical oncologist with an interest in breast cancer treatment. She has been published multiple times and has led several breast and ovarian cancer treatment protocols, including the pioneering use of novel biologic agents such as Herceptin and Avastin. In 2001, Dr. Chap was named, one of “America’s Top Breast Cancer Doctors” by Redbook. Annually, she has also been listed as one of “America’s Top Doctors for Cancer,” published by Michael Connelly. Recognized for her teaching and speaking skills, Dr. Chap has a national reputation where she is frequently called on to speak on the most recent advances in breast cancer treatment.
Visit Dr. Chap at Saint John's Health Center